Using advanced imaging to improve radiation therapy for cancer patients
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
This study is testing a new imaging method that uses special X-rays to help doctors give the right amount of radiation to cancer patients during treatment, making sure the tumors get the care they need while protecting healthy tissues.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10732389 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique called X-ray-induced Acoustic Computed Tomography (XACT) to enhance the accuracy of radiation therapy for cancer patients. By using pulsed X-rays that generate acoustic waves, the study aims to create a 3D imaging system that can provide real-time dosimetry information during treatment. This approach will help medical physicists monitor the radiation dose delivered to tumors, ensuring that patients receive the optimal amount of treatment while minimizing exposure to surrounding healthy tissues.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing radiation therapy who require accurate monitoring of their treatment dosages.
Not a fit: Patients who are not receiving radiation therapy or those with conditions that do not involve tumor treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise radiation therapy, improving treatment outcomes for cancer patients.
How similar studies have performed: Previous research has shown promise in using imaging techniques for dosimetry in radiation therapy, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Xiang, Liangzhong Shawn — University of California-Irvine
- Study coordinator: Xiang, Liangzhong Shawn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.